Known targets — ChEMBL curated mechanism
ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D
The experimentally established mechanism targets of Glycine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glycine SCHEMBL223345 | 0.96 | CA4 (0.47) | — | |
| Glycine SCHEMBL2473796 | 0.93 | CA4 (0.39) | — | |
| Glycine SCHEMBL2161269 | 0.92 | CA4 (0.44) | — | |
| Glycine SCHEMBL5689090 | 0.92 | CA4 (0.44) | — | |
| Glycine SCHEMBL5943682 | 0.92 | CA4 (0.44) | — | |
| Glycine SCHEMBL6753488 | 0.92 | CA4 (0.44) | — | |
| Glycine SCHEMBL4728488 | 0.92 | CA4 (0.44) | — | |
| Glycine SCHEMBL2405749 | 0.92 | — | — | |
| Glycine SCHEMBL3121145 | 0.92 | CA4 (0.44) | — | |
| Glycine SCHEMBL5187484 | 0.92 | CA4 (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4446300-B1 | PREPARATION METHODS OF ALUMINIUM FLUORIDE COMPLEXES | TRASIS S A (BE) | 2025-11-26 | — | — | EP | claimed |
| EP-4446300-A1 | PREPARATION METHODS OF ALUMINIUM FLUORIDE COMPLEXES | Trasis S.A. (BE) | 2024-10-16 | — | — | EP | claimed |
| US-20260116897-A1 | PREPARATION METHODS OF ALUMINIUM FLUORIDE COMPLEXES | TRASIS S A (BE) | 2026-04-30 | — | — | US | disclosed |
| EP-4446300-B1 | PREPARATION METHODS OF ALUMINIUM FLUORIDE COMPLEXES | TRASIS S A (BE) | 2025-11-26 | — | — | EP | disclosed |
| EP-4446300-A1 | PREPARATION METHODS OF ALUMINIUM FLUORIDE COMPLEXES | Trasis S.A. (BE) | 2024-10-16 | — | — | EP | disclosed |
| EP-1627866-B1 | CARBOXYLIC ACID COMPOUND AND MEDICINE CONTAINING THE SAME | KOWA CO (JP) | 2008-12-24 | — | — | EP | disclosed |
| US-20070010700-A1 | Safety containers for biologically active substances and method for producing said container | BAXTER INTERNATIONAL INC (US) | 2007-01-11 | — | — | US | disclosed |
| US-7109242-B2 | Carboxylic compound and medicine comprising the same | KOWA COMPANY, LTD. (JP) | 2006-09-19 | — | — | US | disclosed |
| EP-1627866-A1 | CARBOXYLIC ACID COMPOUND AND MEDICINE CONTAINING THE SAME | Kowa Company Ltd. (JP) | 2006-02-22 | — | — | EP | disclosed |
| EP-1585679-A1 | SAFETY CONTAINERS FOR BIOLOGICALLY ACTIVE SUBSTANCES AND METHOD FOR PRODUCING SAID CONTAINER | Baxter Healthcare S.A. (CH) | 2005-10-19 | — | — | EP | disclosed |
| US-20050009909-A1 | Carboxylic compound and medicine comprising the same | KOWA COMPANY, LTD. (JP) | 2005-01-13 | — | — | US | disclosed |
| WO-2004063036-A1 | SAFETY CONTAINERS FOR BIOLOGICALLY ACTIVE SUBSTANCES AND METHOD FOR PRODUCING SAID CONTAINER | BAXTER HEALTHCARE S.A. (CH) | 2004-07-29 | — | — | WO | disclosed |
| EP-0241804-B1 | PRESERVED ANTACID PREPARATIONS | BAYER AG (DE) | 1992-01-15 | — | — | EP | disclosed |
| EP-0241804-A2 | Preserved antacid preparations | BAYER AG (DE) | 1987-10-21 | — | — | EP | disclosed |